Goodwin is growing its Pacific team, announcing Monday it is bringing in a life sciences and technology transactions expert, David Chen, as a partner in its offices in Hong Kong and Santa Monica, California. He advises clients in the life sciences and technology industries in strategic collaborations and partnerships, joint ventures, intellectual property transactions and general commercial matters as well as data protection and privacy matters. "David's invaluable licensing and strategic collaborations experience, particularly in the biotech, digital health, and medical device fields, enhances our life cycle offering which advises over 1,700 global life sciences clients spanning from big pharma to emerging companies," Mitchell Bloom, Life Sciences Chair, said to Law360. "We are thrilled to welcome David to the firm as he joins our team on the West Coast."